Influenza vaccines: a review and rationale for use in developed and underdeveloped countries.
Multiple studies have demonstrated that influenza infection results in considerable morbidity and mortality, as well as other economic consequences, such as school and work absenteeism. Influenza vaccine has been shown to be both cost-effective and cost-saving. Despite this, the influenza vaccine appears to be under-utilized throughout the world, with significant variations both between countries and within countries over time. Data will be discussed that provide a rationale for the use of the influenza vaccine to protect the public health. Recommendations for the use of the influenza vaccine in various countries and guidelines for influenza vaccine use worldwide will be proposed.
Mayo Vaccine Research Group, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA. poland.gregory@mayo.edu
G A
GA
Poland
S T
ST
Rottinghaus
R M
RM
Jacobson
D000328:Adult; D002648:Child; D003362:Cost-Benefit Analysis; D003906:Developing Countries / Q000191:economics; D006801:Humans; D007252:Influenza Vaccines / Q000191:economics / Q000494:pharmacology*; D007251:Influenza, Human / Q000191:economics / Q000517:prevention & control; D011634:Public Health / Q000191:economics; D014611:Vaccination / Q000191:economics / Q000706:statistics & numerical data*
D007252:Influenza Vaccines